Diabetes Mellitus Type 1

Type 1 diabetes mellitus is an autoimmune condition where the body’s immune system mistakenly attacks insulin-producing beta cells in the pancreas. This leads to little or no insulin production, resulting in elevated blood glucose levels. It typically develops in children, adolescents, or young adults, but can occur at any age. Symptoms include increased thirst, frequent urination, fatigue, and unexplained weight loss. Management requires lifelong insulin therapy, regular blood glucose monitoring, and a balanced diet. Patients must also be vigilant about preventing complications, such as hypoglycemia and long-term effects on eyes, kidneys, and nerves. Research continues to explore potential advancements, including artificial pancreas systems and immunotherapy, to improve management and outcomes for those living with Type 1 diabetes.

    Related Conference of Diabetes Mellitus Type 1

    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France
    June 22-23, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    July 20-21, 2026

    6th World Congress on Endocrine and Diabetes

    Paris, France
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    August 20-21, 2026

    6th Annual Summit on Diabetes and Endocrinology

    Paris, France
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France
    March 29-30, 2027

    8th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands

    Diabetes Mellitus Type 1 Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in